中文摘要：研究分析了以稳定乳状液为佐剂对重组杆状病毒表达的H5流感疫苗的影响。结果表明，单独使用稳定乳状剂作为rH5疫苗佐剂对健康成年人而言是有效的，试验选取的3个剂量均能达到一般疫苗转阴率的标准；其中15ug剂量组能够达到转阴率和HI抗体滴度≥40的双重标准。该试验结果为SE作为H5疫苗佐剂的临床应用提供了科学依据。
外文摘要：Background: Influenza A viruses of the H5 subtype have been identified as important targets for development of vaccines. Achievement of potentially protective antibody responses against pandemic strains has usually required the use of adjuvants. Objectives: We evaluated a candidate A/Indonesia/05/2005 (H5) vaccine generated by baculovirus expression of recombinant hemagglutinin (HA) protein with or without stable emulsion (SE) as an adjuvant. Methods: Healthy subjects 18-49 years old were randomized (1:1:1:1) to receive two doses of rHA at 7.5 ug per dose (no adjuvant), or 3.8 ug, 7.5 ug, or 15 ug per dose formulated with 2% SE separated by 21 days, and serum from day 0, 21, 42, and 201 assessed by hemagglutination-inhibition. Results: 341 subjects were enrolled in the study and 321 received two doses of vaccine. Vaccination was well tolerated in all groups. After two doses, seroconversion was noted in only 9% (95% confidence interval 4%, 17%) of recipients of unadjuvanted vaccine at 7.5 ug, but in 70% (59%, 80%), 76% (65%, 85%), and 83% (73%, 91%) of those receiving adjuvanted vaccine at 3.8 ug, 7.5 ug, or 15 ug respectively. Conclusions: Stable emulsion alone is an effective adjuvant for rH5 vaccine in healthy adults. All three adjuvanted dose groups met the current criterion for seroconversion rate for pandemic vaccines. This dose-ranging study also identified a group (15 ug per dose formulated with 2% SE) that met the criteria for both seroconversion and percentage of subjects achieving an HI antibody titer >= 40. These Phase 2 data support the further clinical development of SE adjuvanted Panblok H5. The protocol was approved by the relevant Institutional Review Board for each study site, and the study was conducted in accordance with the Declaration of Helsinki, International Conference of Harmonisation-Good Clinical Practice, and all applicable laws and regulations. All participants provided written informed consent before study procedures.
外文关键词：Influenza; Pandemic; Vaccine; Adjuvant; Recombinant HA
作者：Treanor, JJ; Chu, L; Essink, B; Muse, D; El Sahly, HM; Izikson, R; Goldenthal, KL; Patriarca, P; Dunkle, LM
作者单位：罗切斯特大学
期刊名称：VACCINE
期刊影响因子：3.413
出版年份：2017
出版刊次：2
点击下载：稳定乳状液是重组杆状病毒表达的H5流感病毒疫苗的有效佐剂